Abstract: In this article, a novel single-phase integrated bidirectional onboard charger based on a symmetrical six-phase induction motor is proposed. The charger has grid-to-vehicle, vehicle-to-grid, ...
The biggest stories of the day delivered to your inbox.
Cadisegliatin acts in the liver to increase the activity of glucokinase, an enzyme that plays a role in regulating blood glucose levels. A phase 3 clinical trial has begun enrolling patients to assess ...
As other pharmas drop next-gen obesity assets, Eli Lilly’s experimental oral GLP-1 has prompted weight loss up to an average of 27.3 pounds in the first of two pivotal trials, queuing up plans for a ...
GLIX1, a first-in-class small molecule, targets DNA repair vulnerabilities, offering potential glioblastoma therapy. Hemispherian will initiate a phase 1 trial to evaluate GLIX1's safety, tolerability ...
Efficacy and safety of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: A prospective, single-arm, phase II trial. This is an ASCO Meeting ...
Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...
Eli Lilly’s oral GLP-1 receptor agonist orforglipron can significantly lower blood sugar levels in patients with type 2 diabetes, according to preliminary Phase III data released Thursday. The Big ...
Initiated in December 2024, the Phase 2b ZUPREME-1 trial is designed to evaluate five target doses of petrelintide up to 9 mg over 42 weeks of treatment. Zealand Pharma remains on track to initiate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results